Cargando…
Ophthalmic Formulation Containing Nilvadipine Nanoparticles Prevents Retinal Dysfunction in Rats Injected with Streptozotocin
Retinopathy leads to irreparable vision loss via capillary closure and areas of nonperfusion. However, the current instillation systems do not allow a sufficient amount of drug required to treat retinopathy to reach the posterior segment (retina); therefore, a new formulation targeting the posterior...
Autores principales: | Deguchi, Saori, Otake, Hiroko, Nakazawa, Yosuke, Hiramatsu, Noriko, Yamamoto, Naoki, Nagai, Noriaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5751321/ https://www.ncbi.nlm.nih.gov/pubmed/29244747 http://dx.doi.org/10.3390/ijms18122720 |
Ejemplares similares
-
Instillation of Ophthalmic Formulation Containing Nilvadipine Nanocrystals Attenuates Lens Opacification in Shumiya Cataract Rats
por: Goto, Ryoka, et al.
Publicado: (2021) -
Therapeutic Effect of Cilostazol Ophthalmic Nanodispersions on Retinal Dysfunction in Streptozotocin-Induced Diabetic Rats
por: Nagai, Noriaki, et al.
Publicado: (2017) -
Combination of Lanosterol and Nilvadipine Nanosuspensions Rescues Lens Opacification in Selenite-Induced Cataractic Rats
por: Deguchi, Saori, et al.
Publicado: (2022) -
Hydrogel Formulations Incorporating Drug Nanocrystals Enhance the Therapeutic Effect of Rebamipide in a Hamster Model for Oral Mucositis
por: Nagai, Noriaki, et al.
Publicado: (2020) -
Energy-dependent endocytosis is responsible for drug transcorneal penetration following the instillation of ophthalmic formulations containing indomethacin nanoparticles
por: Nagai, Noriaki, et al.
Publicado: (2019)